Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Mar 6, we maintained our Neutral recommendation on MasterCard Inc. ( MA - Analyst Report ) based on its strong fundamentals that are poised to generate robust results once the global economic volatility stabilizes. However, intense competition and regulatory challenges mitigate the desired upside currently.
Why Kept Neutral?
Estimates for this electronic payment processor witnessed minor corrections since the company reported its fourth-quarter 2012 results on Jan 31. MasterCard’s fourth-quarter earnings per share of $4.86 topped the Zacks Consensus Estimate, although revenue was in line with the latter at $1.9 billion. Both earnings and revenue outpaced the year-ago results.
The upbeat results reflected better pricing, increased number of processed transactions, as well as strong gross dollar volumes (GDV) growth from an array of diversified and user-friendly products. Modest growth in operating expenses also supported the margins’ upside.
Moreover, MasterCard’s liquidity remains healthy with no long-term debt as well as an operating cash flow of $2.95 billion at the end of 2012 and an unused revolving credit facility worth $3.0 billion. Strong liquidity not only strengthens the operating leverage but paves the way for effective capital deployment to enhance long-term growth.
However, caution is raised over MasterCard’s resilience and ability to raise prices. Moreover, currency fluctuations, the detrimental effects of the regulatory changes, increased competition along with higher litigation and operating expenses will continue to moderate growth in the upcoming quarters.
Following the release of the fourth-quarter results, the Zacks Consensus Estimate for 2013 inched up 2 cents to $25.48 per share in the last 30 days. Conversely, the Zacks Consensus Estimate for 2014 edged down 2 cents to $30.02 per share in the last 30 days. With the Zacks Consensus Estimates for both 2013 and 2014 providing no clear directional pressure in the near term, MasterCard now has a Zacks Rank #3 (Hold).
Other Financial Stocks That Warrant a Look
While we see no clear directional pressure on MasterCard in the near term, other stocks in the financial sector that are outperforming include Moody’s Corp. ( MCO - Analyst Report ) , Viad Corp. ( VVI - Snapshot Report ) and Vantiv Inc. ( VNTV - Snapshot Report ) . All of these carry a Zacks Rank #1 (Strong Buy).
Read the full Analyst Report on MA
Read the full Snapshot Report on VNTV
Read the full Analyst Report on MCO
Read the full Snapshot Report on VVI